Dogwood Therapeutics, Inc.
DWTX
$4.90
$0.102.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -41.37% | -238.84% | -117.25% | 18.70% | -17.05% |
| Total Depreciation and Amortization | 39.34% | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -10.27% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 74.00% | 3,810.29% | -36.67% | 7.12% | -6.27% |
| Change in Net Operating Assets | 88.76% | -269.38% | 1,332.32% | -58.56% | 141.80% |
| Cash from Operations | 23.63% | -573.72% | -12.12% | 13.41% | 36.20% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -80.42% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 99.43% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -51.88% | 21,926.64% | -104.83% | -- | -- |
| Foreign Exchange rate Adjustments | 100.83% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -78.99% | 1,406.42% | -253.02% | 168.35% | 36.20% |